India’s herbal healthcare sector is preparing for a new growth phase, as traditional medicine blends with modern science to produce validated, affordable, and globally competitive solutions. This momentum was on full display at the recently concluded two-day CSIR Startup Conclave held in Lucknow, where research institutions, startups, and policymakers joined forces to demonstrate how herbal formulations are moving from laboratories to the marketplace, with diabetes drug BGR-34 emerging as the star attraction. The conclave showcased the work of Four Lucknow-based laboratories of the Council of Scientific and Industrial Research (CSIR) .
